Biochemical paths in humans and cells: Frontiers of AMS bioanalysis

Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms

Volumn 259, Issue 1, 2007, Pages 745-751

  Vogel, J S ^a   Palmblad, N M ^a   Ognibene, T ^a   Kabir, M M ^a   Buchholz, B A ^a   Bench, G ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

AMS; Biomedical; Drug; Human; Metabolism; Nutrition; Phamacokinetics; Pharmaceutical; Yeast

Indexed keywords

BIOCHEMISTRY; BIOMEDICAL ENGINEERING; MASS SPECTROMETRY; PARTICLE ACCELERATORS;

BIOCHEMICAL EVENTS; CHEMICAL PASSAGES; NON-ISOTOPIC METHODS;

CELL CULTURE;

EID: 34248140795     PISSN: 0168583X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nimb.2007.01.215     Document Type: Article

References (44)

1. Turteltaub K.W., Felton J.S., Gledhill B.L., Vogel J.S., Southon J.R., Caffee M.W., Finkel R.C., Nelson D.E., Proctor I.P., and Davis J.C. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine-carcinogens to DNA. Proc. Natl. Acad. Sci. 87 (1990) 5288
2. Kobayashi K., Yumoto S., Nagai H., Hosoyama Y., Imamura M., Masuzawa S., Koizumi Y., and Yamashita H. Al-26 tracer experiment by accelerator mass-spectrometry and its application to the studies for amyotrophic-lateral-sclerosis and alzheimers-disease. Proc. Jpn. Acad. B 66 (1990) 189
3. Elmore D., Bhattacharyya M.H., Saccogibson N., and Peterson D.P. Ca-41 as a long-term biological tracer for bone-resorption. Nucl. Instr. and Meth. B 52 (1990) 531
4. Barker J., Day J.P., Aitken T.W., Charlesworth T.R., Cunningham R.C., Drumm P.V., Lilley J.S., Newton G.W.A., and Smithson M.J. Development of 26Al accelerator mass spectrometry for biological and toxicological applications. Nucl. Instr. and Meth. B 52 (1990) 540
5. 14C at low energies. Nucl. Instr. and Meth. B 123 (1997) 148
6. Hughey B.J., Klinkowstein R.E., Shefer R.E., Skipper P.L., Tannenbaum S.R., and Wishnok J.S. Design of a compact 1 MV AMS system for biomedical research. Nucl. Instr. and Meth. B 123 (1997) 153
7. Turteltaub K.W., Mauthe R.J., Dingley K.H., Vogel J.S., Frantz C.E., Garner R.C., and Shen N. MeIQx-DNA adduct formation in rodent and human tissues at low doses. Mutat Res. 12 (1997) 243
8. Dingley K.H., Freeman S.P., Nelson D.O., Garner R.C., and Turteltaub K.W. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats. Drug Metab. Dispos. 26 (1998) 825
9. 14C-folic acid. In: Clifford A.J. (Ed). Advances in Experimental Medicine and Biology (1998), Plenum, New York 233
10. 14C-labeled atrazine metabolites in human urine. A. Chem. 70 (1998) 3463
11. Vogel J.S., Turteltaub K.W., Felton J.S., Gledhill B.L., Nelson D.E., Southon J.R., Proctor I.D., and Davis J.C. Application of AMS to biomedical sciences. Nucl. Instr. and Meth. B 52 (1990) 524
12. 41Ca for measuring dietary perturbations of bone resorption, Nucl. Instr. and Meth. B, these Proceedings, doi:10.1016/j.nimb.2007.02.004.
13. Steinhausen C., Kislinger G., Winklhofer C., Beck E., Hohl C., Nolte E., Ittel T.H., and Alvarez-Bruckmann M.J. Investigation of the aluminium biokinetics in humans: a 26Al tracer study. Food Chem. Toxicol. 42 (2004) 363
14. 41Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal disease patients. Clin. Chem. (2005) 2095
15. Mullis K., Faloona F., Scharf S., Saiki R., Horn G., and Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol. 51 (1986) 263
16. Lowe J.B. Clinical applications of gene probes in human genetic disease, malignancy, and infectious disease. Clin. Chim. Acta 157 (1986) 1
17. Dingley K.H., Curtis K.D., Nowell S., Felton J.S., Lang N.P., and Turteltaub K.W. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol. Biomar. Prev. 8 (1999) 507
18. Mally A., Zepnik H., Wanek P., Eder E., Dingley K., Ihmels H., Volkel W., and Dekant W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17 (2004) 234
19. Xie Q., Sun H., Liu Y., Ding X., Fu D., and Liu K. Adduction of biomacromolecules with acrylamide (AA) in mice at environmental dose levels studied by accelerator mass spectrometry. Toxicol. Lett. 163 (2006) 103
20. Dingley K.H., Ubick E.A., Chiarappa-Zucca M.L., Nowell S., Abel S., Ebeler S.E., Mitchell A.E., Burns S.A., Steinberg F.M., and Clifford A.J. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr. Cancer 46 (2003) 212
21. Li H., Cheng Y., Wang H., Sun H., Liu Y., Liu K., and Peng S. Inhibition of nitrobenzene-induced DNA and hemoglobin adductions by dietary constituents. Appl. Radiat. Isotopes 58 (2003) 291
22. Ebeler S.E., Dingley K.H., Ubick E., Abel S., Mitchell A.E., Burns S.A., Steinberg F.M., and Clifford A.J. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp. Clin. Res. 31 (2005) 19
23. Vogel J.S., Keating G.A., and Buchholz B.A. Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. Environ. Health Pers. 110S 6 (2002) 1031
24. Vogel J.S., Grant P.G., Buchholz B.A., Dingley K.H., and Turteltaub K.W. Attomole quantitation of protein separations with accelerator mass spectrometry. Electrophoresis 22 (2002) 2037
25. 14C-labeled 8-oxodG into the DNA of human breast cancer cells. Bioorg. Med. Chem. Lett. 15 (2005) 3627
26. Shan G., Huang W., Gee S.J., Buchholz B.A., Vogel J.S., and Hammock B.D. Isotope-labeled immunoassays without radiation waste. Proc. Natl. Acad. Sci. 97 (2000) 2445
27. Lu C.M., Burton D.W., Fitzgerald R.L., Deftos L.J., Buchholz B.A., Vogel J.S., and Herold D.A. Mass spectrometric immunoassay for parathyroid related protein. A. Chem. 74 (2002) 5507
28. Miyashita M., Presley J.M., Buchholz B.A., Lam K.S., Lee Y.M., Vogel J.S., and Hammock B.D. Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry. Proc. Natl. Acad. Sci. 98 (2001) 4403
29. Sandhu P., Vogel J.S., Rose M.J., Ubick E.A., Brunner J.E., Wallace M.A., Adelsberger J.K., Baker M.P., Henderson P.T., Pearson P.G., and Baillie T.A. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range. Drug Metab. Dispos. 32 (2004) 1254
30. Lappin G., and Garner R.C. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nat. Rev. Drug Discov. 2 (2003) 233
31. 14C-isotope measurement in biomedical accelerator mass spectrometry. Anal. Bioanal. Chem. 78 (2004) 356
32. Wilding I.R., and Bell J.A. Improved early clinical development through human microdosing studies. Drug Discov. Today 10 (2005) 890
33. Balani S.K., Nagaraja N.V., Qian M.G., Costa A.O., Daniels J.S., Yang H., Shimoga P.R., Wu J.T., Gan L.S., Lee F.W., and Miwa G.T. Evaluation of microdosing to assess pharmacokinetic linearity in rats using LC-MS/MS. Drug Metab. Dispos. 34 (2006) 384
34. Dueker S.R., Lin Y.M., Buchholz B.A., Schneider P.D., Lame M.W., Segall H.J., Vogel J.S., and Clifford A.J. Long-term kinetic study of beta-carotene, using accelerator mass spectrometry in an adult volunteer. J. Lipid Res. 41 (2000) 1790
35. Lemke S.L., Dueker S.R., Follett J.R., Lin Y., Carkeet C., Buchholz B.A., Vogel J.S., and Clifford A.J. Absorption and retinol equivalence of beta-carotene in humans is influenced by dietary vitamin A intake. J. Lipid Res. 44 (2003) 1591
36. Lin Y., Dueker S.R., Follett J.R., Fadel J.G., Arjoumand A., Schneider P.D., Miller J.W., Green R., Buchholz B.A., Vogel J.S., Phair R.D., and Clifford A.J. Quantitation of in vivo human folate metabolism. Am. J. Clin. Nutr. 80 (2004) 680
37. 14C urea breath tests in children. Br. J. Radiol. 75 (2002) 982
38. Choi M.H., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab. Dispos. 33 (2005) 714
39. Buchholz B.A., Fultz E., Haack K.W., Vogel J.S., Gilman S.D., Gee S.J., Hammock B.D., Hui X., Wester R.C., and Maibach H.I. HPLC-AMS measurement of atrazine metabolites in human urine after dermal exposure. A. Chem. 71 (1999) 3519
40. Libby W.F., Berger R., Mead J.F., Alexander G.B., and Ross J.F. Replacement rates for human tissue from atmospheric radiocarbon. Science 146 (1964) 1170
41. Shapiro S.D., Endicott S.K., Province M.A., Pierce J.A., and Campbell E.J. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest. 87 (1991) 1828
42. Spalding K.L., Bhardwaj R.D., Buchholz B.A., Druid H., and Frisen J. Retrospective birth dating of cells in humans. Cell 122 (2005) 133
43. Spalding K.L., Buchholz B.A., Bergman L.E., Druid H., and Frisen J. Forensics: age written in teeth by nuclear tests. Nature 437 (2005) 333
44. T. Ognibene, G. Bench, T.A. Brown, J.S. Vogel, Ion-optics calculations and preliminary precision estimates of the gas-capable ion source for the 1-MV LLNL BioAMS spectrometer, Nucl. Instr. and Meth., these Proceedings, doi:10.1016/j.nimb.2007.01.148.